|
|
| (10 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| − | | + | {{ft|D}} |
| − | ''which risk factors make covid worse/better/no effect'' | + | ''which risk factors / underlying conditions make covid worse/better/no effect;'' |
| | | | |
| | '''[[RSP - identifying risk factors]]''' | | '''[[RSP - identifying risk factors]]''' |
| Zeile 40: |
Zeile 40: |
| | '''[[RSP - HIV]]''' | | '''[[RSP - HIV]]''' |
| | | | |
| − | '''[[RSP - DIS Children]]''' | + | '''[[Children_with_covid19_disease|RSP - DIS Children]]''' |
| | | | |
| | '''[[RSP - DIS Elderly]]''' | | '''[[RSP - DIS Elderly]]''' |
| Zeile 47: |
Zeile 47: |
| | | | |
| | '''[[RSP - DIS Race]]''' | | '''[[RSP - DIS Race]]''' |
| − |
| |
| − | ===007=== rsp and secondary d
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32486196|t=2020. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?|pdf=|usr=007}}
| |
| − | {{tp|p=32455539|t=2020. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.|pdf=|usr=007}}
| |
| − | {{tp|p=32423094|t=2020. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32472662|t=2020. COVID-19 and diabetes: Is there enough evidence?|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32443899|t=2020. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32498262|t=2020. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.|pdf=|usr=007}}
| |
| − | {{tp|p=32498230|t=2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.|pdf=|usr=007}}
| |
| − | {{tp|p=32496205|t=2020. Why African Americans Are a Potential Target for COVID-19 Infection in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32449782|t=2020. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32271393|t=2020. Medical Rehabilitation in Pandemics: Towards a New Perspective.|pdf=|usr=007}}
| |
| − | {{tp|p=32482654|t=2020. Dr. Favalli, et al reply.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32475104|t=2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.|pdf=|usr=007}}
| |
| − | {{tp|p=32314329|t=2020. ACE-2 och coronavirus - en fraga om balans och dynamik?|pdf=|usr=007}}
| |
| − | {{tp|p=32471831|t=2020. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".|pdf=|usr=007}}
| |
| − | {{tp|p=32444383|t=2020. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.|pdf=|usr=007}}
| |
| − | {{tp|p=32467553|t=2020. Smoking amidst the COVID-19 Pandemic - the invisible threat?|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32442932|t=2020. Experiencia COVID-19 en un sanatorio privado de Buenos Aires durante el primer mes de la pandemia: 26 casos.|pdf=|usr=007}}
| |
| − | {{tp|p=32481381|t=2020. A case report with COVID-19 during perioperative period of lobectomy.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32384516|t=2020. Novel coronavirus 2019 (COVID-19): A case report and review of treatments.|pdf=|usr=007}}
| |
| − | {{tp|p=32502054|t=2020. A 3-month-old child with COVID-19: A case report.|pdf=|usr=007}}
| |
| − | {{tp|p=32502034|t=2020. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32408731|t=2020. Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.|pdf=|usr=007}}
| |
| − | {{tp|p=32380802|t=2020. Cardiovascular system and COVID-19: perspectives from a developing country.|pdf=|usr=007}}
| |
| − | {{tp|p=32449614|t=2020. Gender differences in patients with COVID-19: a narrative review.|pdf=|usr=007}}
| |
| − | {{tp|p=32447949|t=2020. Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation.|pdf=|usr=007}}
| |
| − | {{tp|p=32432433|t=2020. Severity of COVID-19: The importance of being hypertensive.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32457226|t=2020. COVID-19 in MS: Initial observations from the Pacific Northwest.|pdf=|usr=007}}
| |
| − | {{tp|p=32414755|t=2020. COVID-19 and MS disease-modifying therapies.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32503140|t=2020. Human T leukaemia Type 1 and COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32384078|t=2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.|pdf=|usr=007}}
| |
| − | {{tp|p=32497090|t=2020. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.|pdf=|usr=007}}
| |
| − | {{tp|p=32420710|t=2020. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.|pdf=|usr=007}}
| |
| − | {{tp|p=32385979|t=2020. Diagnosis and recovery from severe acute respiratory syndrome coronavirus 2 infection is challenging in kidney patients: tests are an issue.|pdf=|usr=007}}
| |
| − | {{tp|p=32491298|t=2020. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32458823|t=2020. Infeccion por coronavirus Covid-19 y lactancia materna: una revision exploratoria.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32491116|t=2020. A brief-review of the risk factors for covid-19 severity.|pdf=|usr=007}}
| |
| − | {{tp|p=32491091|t=2020. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.|pdf=|usr=007}}
| |
| − | {{tp|p=32491053|t=2020. Diabetes and covid-19: more than the sum of two morbidities.|pdf=|usr=007}}
| |
| − | {{tp|p=32507709|t=2020. Sindrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.|pdf=|usr=007}}
| |
| − | {{tp|p=32512263|t=2020. COVID-19 in rheumatic disease patients on immunosuppressive agents.|pdf=|usr=007}}
| |
| − | {{tp|p=32460453|t=2020. COVID-19 in Singapore - a case series from primary care.|pdf=|usr=007}}
| |
| − | {{tp|p=32466735|t=2020. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32460390|t=2020. Covid-19 in solid organ transplant recipients: A single center experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32429038|t=2020. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32395790|t=2020. COVID-19 and Cardiovascular diseases. Scoping review study.|pdf=|usr=007}}
| |
| − | {{tp|p=32395788|t=2020. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series.|pdf=|usr=007}}
| |
| − | {{tp|p=32395787|t=2020. First case of imported and confirmed COVID-19 in Tunisia.|pdf=|usr=007}}
| |
| − | {{tp|p=32394689|t=2020. COVID-19, Renin-angiotensin System and Hematopoiesis.|pdf=|usr=007}}
| |
| − | {{tp|p=32490641|t=2020. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.|pdf=|usr=007}}
| |
| − | {{tp|p=32430957|t=2020. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32456286|t=2020. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32403242|t=2020. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32493200|t=2020. Prevention of COVID-19 infection in the medical population: a possible help from anosmia?.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32396143|t=2020. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.|pdf=|usr=007}}
| |
| − | {{tp|p=32435811|t=2020. COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32512586|t=2020. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.|pdf=|usr=007}}
| |
| − | {{tp|p=32510876|t=2020. Differences in Clinical Characteristics of Covid-19 in Hispanic/Latino Population.|pdf=|usr=007}}
| |
| − | {{tp|p=32510771|t=2020. COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32500942|t=2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.|pdf=|usr=007}}
| |
| − | {{tp|p=32500922|t=2020. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.|pdf=|usr=007}}
| |
| − | {{tp|p=32500666|t=2020. Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus.|pdf=|usr=007}}
| |
| − | {{tp|p=32492485|t=2020. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32400381|t=2020. [De forste kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke aendre medicinering].|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32223839|t=2020. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].|pdf=|usr=007}}
| |
| − | {{tp|p=32065520|t=2020. [First case of neonate infected with novel coronavirus pneumonia in China].|pdf=|usr=007}}
| |
| − | {{tp|p=32294814|t=2020. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32496259|t=2020. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.|pdf=|usr=007}}
| |
| − | {{tp|p=32393678|t=2020. COVID-19: Important Issues for Pediatricians.|pdf=|usr=007}}
| |
| − | {{tp|p=32412915|t=2020. Managing Children with Renal Diseases during COVID-19 Pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32487797|t=2020. The seXY side of COVID-19: what is behind female protection?|pdf=|usr=007}}
| |
| − | {{tp|p=32487793|t=2020. Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.|pdf=|usr=007}}
| |
| − | {{tp|p=32487789|t=2020. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32449528|t=2020. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.|pdf=|usr=007}}
| |
| − | {{tp|p=32470210|t=2020. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.|pdf=|usr=007}}
| |
| − | {{tp|p=32463562|t=2020. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?|pdf=|usr=007}}
| |
| − | {{tp|p=32463545|t=2020. Obesity and COVID-19: an Italian snapshot.|pdf=|usr=007}}
| |
| − | {{tp|p=32445512|t=2020. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.|pdf=|usr=007}}
| |
| − | {{tp|p=32445496|t=2020. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32428380|t=2020. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight.|pdf=|usr=007}}
| |
| − | {{tp|p=32505551|t=2020. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32469426|t=2020. African American children are at higher risk of COVID-19 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32437077|t=2020. Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?|pdf=|usr=007}}
| |
| − | {{tp|p=32501190|t=2020. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.|pdf=|usr=007}}
| |
| − | {{tp|p=32461198|t=2020. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?|pdf=|usr=007}}
| |
| − | {{tp|p=32505834|t=2020. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32463446|t=2020. Familial cluster of SARS-CoV-2 infection associated with a railway journey.|pdf=|usr=007}}
| |
| − | {{tp|p=32250460|t=2020. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.|pdf=|usr=007}}
| |
| − | {{tp|p=32484584|t=2020. COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.|pdf=|usr=007}}
| |
| − | {{tp|p=32479103|t=2020. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.|pdf=|usr=007}}
| |
| − | {{tp|p=32467603|t=2020. Resistance of children to Covid-19. How?|pdf=|usr=007}}
| |
| − | {{tp|p=32463329|t=2020. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.|pdf=|usr=007}}
| |
| − | {{tp|p=32391998|t=2020. De eerste 29 COVID-19-patienten in de kliniek.|pdf=|usr=007}}
| |
| − | {{tp|p=32391997|t=2020. De eerste honderd opgenomen COVID-19-patienten in het Elisabeth-Tweesteden Ziekenhuis.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32498065|t=2020. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit.|pdf=|usr=007}}
| |
| − | {{tp|p=32237206|t=2020. Obesity and its Implications for COVID-19 Mortality.|pdf=|usr=007}}
| |
| − | {{tp|p=32384387|t=2020. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32384385|t=2020. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
| |
| − | {{tp|p=32459701|t=2020. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32433453|t=2020. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
| |
| − | {{tp|p=32433451|t=2020. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32496337|t=2020. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32482123|t=2020. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32413201|t=2020. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32404786|t=2020. Clinical Analysis of 25 Novel Coronavirus Infections in Children.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32398569|t=2020. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32404791|t=2020. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data.|pdf=|usr=007}}
| |
| − | {{tp|p=32404780|t=2020. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.|pdf=|usr=007}}
| |
| − | {{tp|p=32384398|t=2020. COVID-19 in Neonates and Infants: Progression and Recovery.|pdf=|usr=007}}
| |
| − | {{tp|p=32384397|t=2020. Children Hospitalized With Severe COVID-19 in Wuhan.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32492251|t=2020. Clinical manifestations of children with COVID-19: A systematic review.|pdf=|usr=007}}
| |
| − | {{tp|p=32483934|t=2020. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.|pdf=|usr=007}}
| |
| − | {{tp|p=32392382|t=2020. COVID-19: A message of hope from a young girl with severe cystic fibrosis.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32409480|t=2020. Caring for Newborns Born to Mothers with COVID-19: More Questions than Answers.|pdf=|usr=007}}
| |
| − | {{tp|p=32404431|t=2020. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32419564|t=2020. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32449876|t=2020. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone.|pdf=|usr=007}}
| |
| − | {{tp|p=32434874|t=2020. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32338566|t=2020. Experiences and Insights from the Early US COVID-19 Epicenter: A Rapid Assessment Procedure Informed Clinical Ethnography Case Series.|pdf=|usr=007}}
| |
| − | {{tp|p=32286091|t=2020. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?|pdf=|usr=007}}
| |
| − | {{tp|p=32442308|t=2020. The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32374550|t=2020. Covid-19: la troublante decouverte des possibles vertus de la nicotine.|pdf=|usr=007}}
| |
| − | {{tp|p=32374540|t=2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32374539|t=2020. Pandemie de COVID-19 : aspects cardiologiques.|pdf=|usr=007}}
| |
| − | {{tp|p=32462846|t=2020. COVID-19: differences de symptomatologie entre la Chine et l'Europe.|pdf=|usr=007}}
| |
| − | {{tp|p=32462841|t=2020. Obesite et risque de COVID-19 severe.|pdf=|usr=007}}
| |
| − | {{tp|p=32432429|t=2020. COVID-19: elements de connaissances concernant les enfants.|pdf=|usr=007}}
| |
| − | {{tp|p=32401442|t=2020. Les bloqueurs du systeme renine-angiotensine-aldosterone en temps de pandemie Covid-19 : amis ou ennemis ?|pdf=|usr=007}}
| |
| − | {{tp|p=32496707|t=2020. La rehabilitation: indispensable pour les survivants d'un COVID-19 severe.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32348050|t=2020. Prise en charge des patients avec maladies digestives et hepatiques durant la pandemie COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32348048|t=2020. COVID-19 : impact pediatrique.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32458742|t=2020. Nurse infected with Covid-19 from a provisional dengue patient.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32467096|t=2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: meta-analysis.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32474561|t=2020. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.|pdf=|usr=007}}
| |
| − | {{tp|p=32482915|t=2020. Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.|pdf=|usr=007}}
| |
| − | {{tp|p=32436996|t=2020. The value of clinical parameters in predicting the severity of COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32418216|t=2020. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32510106|t=2020. Clinical Presentation of COVID19 in Dementia Patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32418199|t=2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32459046|t=2020. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32492092|t=2020. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.|pdf=|usr=007}}
| |
| − | {{tp|p=32505466|t=2020. Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32505846|t=2020. The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?|pdf=|usr=007}}
| |
| − | {{tp|p=32512494|t=2020. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?|pdf=|usr=007}}
| |
| − | {{tp|p=32441063|t=2020. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32472989|t=2020. Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?|pdf=|usr=007}}
| |
| − | {{tp|p=32508078|t=2020. SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?|pdf=|usr=007}}
| |
| − | {{tp|p=32480326|t=2020. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?|pdf=|usr=007}}
| |
| − | {{tp|p=32480327|t=2020. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.|pdf=|usr=007}}
| |
| − | {{tp|p=32460086|t=2020. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32497334|t=2020. A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32497297|t=2020. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.|pdf=|usr=007}}
| |
| − | {{tp|p=32497290|t=2020. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32508329|t=2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.|pdf=|usr=007}}
| |
| − | {{tp|p=32500549|t=2020. Clinical update on COVID-19 in pregnancy: A review article.|pdf=|usr=007}}
| |
| − | {{tp|p=32423324|t=2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32390643|t=2020. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?|pdf=|usr=007}}
| |
| − | {{tp|p=32441753|t=2020. Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32441743|t=2020. A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2.|pdf=|usr=007}}
| |
| − | {{tp|p=32504532|t=2020. Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.|pdf=|usr=007}}
| |
| − | {{tp|p=32479632|t=2020. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020.|pdf=|usr=007}}
| |
| − | {{tp|p=32401228|t=2020. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an answer?|pdf=|usr=007}}
| |
| − | {{tp|p=32404798|t=2020. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32348627|t=2020. Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32432681|t=2020. Nasal ACE2 Levels and COVID-19 in Children.|pdf=|usr=007}}
| |
| − | {{tp|p=32391864|t=2020. COVID-19 and Racial/Ethnic Disparities.|pdf=|usr=007}}
| |
| − | {{tp|p=32215579|t=2020. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.|pdf=|usr=007}}
| |
| − | {{tp|p=32511673|t=2020. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.|pdf=|usr=007}}
| |
| − | {{tp|p=32250408|t=2020. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.|pdf=|usr=007}}
| |
| − | {{tp|p=32293639|t=2020. COVID-19 and African Americans.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32401283|t=2020. Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US.|pdf=|usr=007}}
| |
| − | {{tp|p=32392288|t=2020. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.|pdf=|usr=007}}
| |
| − | {{tp|p=32511066|t=2020. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.|pdf=|usr=007}}
| |
| − | {{tp|p=32369410|t=2020. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.|pdf=|usr=007}}
| |
| − | {{tp|p=32394850|t=2020. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32471013|t=2020. Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32495496|t=2020. Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?|pdf=|usr=007}}
| |
| − | {{tp|p=32502316|t=2020. COVID-19 Infection in Early Post-Operative Period after Liver Transplantation.|pdf=|usr=007}}
| |
| − | {{tp|p=32485314|t=2020. Persistent SARS-CoV-2 infection and the risk for cancer.|pdf=|usr=007}}
| |
| − | {{tp|p=32512287|t=2020. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32320565|t=2020. First Case of Covid-19 in the United States. Reply.|pdf=|usr=007}}
| |
| − | {{tp|p=32320563|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32320562|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32320561|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32320560|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32320559|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32220206|t=2020. Clinical Characteristics of Covid-19 in China. Reply.|pdf=|usr=007}}
| |
| − | {{tp|p=32220205|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
| |
| − | {{tp|p=32220204|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
| |
| − | {{tp|p=32220203|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
| |
| − | {{tp|p=32220202|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32427431|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.|pdf=|usr=007}}
| |
| − | {{tp|p=32427430|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32427429|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32427428|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32329974|t=2020. Mild or Moderate Covid-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32427903|t=2020. How to address the coronavirus's outsized toll on people of colour.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32265541|t=2020. Why measles deaths are surging - and coronavirus could make it worse.|pdf=|usr=007}}
| |
| − | {{tp|p=32395965|t=2020. Een man met dyspneu na een COVID-19-pneumonie.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32403153|t=2020. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen.|pdf=|usr=007}}
| |
| − | {{tp|p=32449179|t=2020. Mortality in Older Patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32441771|t=2020. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.|pdf=|usr=007}}
| |
| − | {{tp|p=32445276|t=2020. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.|pdf=|usr=007}}
| |
| − | {{tp|p=32452050|t=2020. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.|pdf=|usr=007}}
| |
| − | {{tp|p=32459882|t=2020. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32455485|t=2020. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities.|pdf=|usr=007}}
| |
| − | {{tp|p=32455475|t=2020. COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.|pdf=|usr=007}}
| |
| − | {{tp|p=32426877|t=2020. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32436622|t=2020. Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32512022|t=2020. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32512021|t=2020. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge.|pdf=|usr=007}}
| |
| − | {{tp|p=32504736|t=2020. Tumor biomarkers predict clinical outcome of COVID-19 patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32458565|t=2020. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32459372|t=2020. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?|pdf=|usr=007}}
| |
| − | {{tp|p=32500773|t=2020. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.|pdf=|usr=007}}
| |
| − | {{tp|p=32470212|t=2020. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32470186|t=2020. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.|pdf=|usr=007}}
| |
| − | {{tp|p=32470174|t=2020. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.|pdf=|usr=007}}
| |
| − | {{tp|p=32470167|t=2020. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32441816|t=2020. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.|pdf=|usr=007}}
| |
| − | {{tp|p=32441789|t=2020. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32437017|t=2020. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.|pdf=|usr=007}}
| |
| − | {{tp|p=32437016|t=2020. Obesity predisposes to the risk of higher mortality in young COVID-19 patients.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32436998|t=2020. Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32505438|t=2020. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.|pdf=|usr=007}}
| |
| − | {{tp|p=32505908|t=2020. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32385130|t=2020. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32467113|t=2020. Presentation and Outcomes of Patients with ESKD and COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32484893|t=2020. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32510598|t=2020. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.|pdf=|usr=007}}
| |
| − | {{tp|p=32433344|t=2020. Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32502117|t=2020. Coronavirus disease 2019 in children: Current status.|pdf=|usr=007}}
| |
| − | {{tp|p=32474598|t=2020. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32488958|t=2020. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.|pdf=|usr=007}}
| |
| − | {{tp|p=32488888|t=2020. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.|pdf=|usr=007}}
| |
| − | {{tp|p=32479133|t=2020. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32406283|t=2020. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32363967|t=2020. A challenging case of psoriasis flare-up after COVID-19 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32433220|t=2020. When life is put on hold, how do we hold on to life? - Challenges and Opportunities in Developmental and Behavioral Pediatrics during COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32394639|t=2020. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?|pdf=|usr=007}}
| |
| − | {{tp|p=32389027|t=2020. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32506937|t=2020. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32506122|t=2020. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.|pdf=|usr=007}}
| |
| − | {{tp|p=32490807|t=2020. Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32502097|t=2020. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32502096|t=2020. Are COVID-19 patients with hypertension at higher risk in China?|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32504741|t=2020. Does type of immunosupression influence the course of Covid-19 infection?|pdf=|usr=007}}
| |
| − | {{tp|p=32490559|t=2020. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.|pdf=|usr=007}}
| |
| − | {{tp|p=32462792|t=2020. Sex-based dimorphism in the SARS-CoV2 virulence.|pdf=|usr=007}}
| |
| − | {{tp|p=32452046|t=2020. Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.|pdf=|usr=007}}
| |
| − | {{tp|p=32498135|t=2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32498581|t=2020. Relationship between pregnancy and coronavirus: what we know.|pdf=|usr=007}}
| |
| − | {{tp|p=32223477|t=2020. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns.|pdf=|usr=007}}
| |
| − | {{tp|p=32369209|t=2020. Clinical characteristics and outcomes of cancer patients with COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32492209|t=2020. ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32314808|t=2020. Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32335609|t=2020. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32409438|t=2020. Treating acute anxiety in patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32409436|t=2020. Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32409434|t=2020. Renin-angiotensin system inhibitors in COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32393596|t=2020. COVID-19 and pulmonary hypertension.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32452350|t=2020. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.|pdf=|usr=007}}
| |
| − | {{tp|p=32461326|t=2020. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32409520|t=2020. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32456720|t=2020. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32449224|t=2020. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32242895|t=2020. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.|pdf=|usr=007}}
| |
| − | {{tp|p=32498078|t=2020. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.|pdf=|usr=007}}
| |
| − | {{tp|p=32423251|t=2020. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS.|pdf=|usr=007}}
| |
| − | {{tp|p=32423249|t=2020. Physical activity/inactivity and COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32397803|t=2020. Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32475157|t=2020. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).|pdf=|usr=007}}
| |
| − | {{tp|p=32270698|t=2020. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
| |
| − | {{tp|p=32233671|t=2020. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32495914|t=2020. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32495849|t=2020. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?|pdf=|usr=007}}
| |
| − | {{tp|p=32441761|t=2020. COVID-19 and QT interval prolongation: more than just drug toxicity?|pdf=|usr=007}}
| |
| − | {{tp|p=32441223|t=2020. COVID-19 and obesity: links and risks.|pdf=|usr=007}}
| |
| − | {{tp|p=32511033|t=2020. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32420884|t=2020. Pathologies cardiovasculaires et Covid-19 : particularites chez les personnes agees.|pdf=|usr=007}}
| |
| − | {{tp|p=32434831|t=2020. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32414813|t=2020. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.|pdf=|usr=007}}
| |
| − | {{tp|p=32493828|t=2020. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.|pdf=|usr=007}}
| |
| − | {{tp|p=32431118|t=2020. [CURRENT KNOWLEDGE ON COVID-19 IN CHILDREN - CAUTIOUS OPTIMISM].|pdf=|usr=007}}
| |
| − | {{tp|p=32437224|t=2020. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.|pdf=|usr=007}}
| |
| − | {{tp|p=32461330|t=2020. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32461328|t=2020. Getting to the heart of the matter of COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32451360|t=2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32364920|t=2020. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32415860|t=2020. Liver Biochemistries in Hospitalized Patients With COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32512611|t=2020. Endocrine Conditions and COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32456489|t=2020. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?|pdf=|usr=007}}
| |
| − | {{tp|p=32383626|t=2020. RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.|pdf=|usr=007}}
| |
| − | {{tp|p=32383624|t=2020. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.|pdf=|usr=007}}
| |
| − | {{tp|p=32458694|t=2020. Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32493070|t=2020. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.|pdf=|usr=007}}
| |
| − | {{tp|p=32476472|t=2020. COVID-19: ACE2centric infective disease?|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32389131|t=2020. A case of COVID-19 with an ultralong incubation period.|pdf=|usr=007}}
| |
| − | {{tp|p=32427018|t=2020. Several neonates reported positive for COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32476537|t=2020. Early experience with COVID-19 patients at academic hospital in Southwestern United States.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32418532|t=2020. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32389117|t=2020. A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}}
| |
| − | {{tp|p=32348232|t=2020. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32506768|t=2020. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.|pdf=|usr=007}}
| |
| − | {{tp|p=32506743|t=2020. No current evidence supporting risk of using Ibuprofen in patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32363628|t=2020. Management of older people during the COVID-19 outbreak: Recommendations from an Italian experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32473603|t=2020. Maternal mortality from COVID-19 in Mexico.|pdf=|usr=007}}
| |
| − | {{tp|p=32438521|t=2020. Update on clinical outcomes of women with COVID-19 during pregnancy.|pdf=|usr=007}}
| |
| − | {{tp|p=32428290|t=2020. Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.|pdf=|usr=007}}
| |
| − | {{tp|p=32510581|t=2020. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32330289|t=2020. Be aware of misdiagnosis-Influenza A H1N1 in a pregnant patient with suspected COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32510283|t=2020. EXPRESS: COVID-19 and stroke in Iran; a case series, and effects on stroke admissions.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32267662|t=2020. Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32418475|t=2020. Who are the Most At-Risk Older Adults in the COVID-19 Era? It's Not Just Those in Nursing Homes.|pdf=|usr=007}}
| |
| − | {{tp|p=32250655|t=2020. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32511148|t=2020. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.|pdf=|usr=007}}
| |
| − | {{tp|p=32364930|t=2020. Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32364928|t=2020. Dental sleep medicine perspectives post-COVID-19: interprofessional adaptation and directions.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32441246|t=2020. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?|pdf=|usr=007}}
| |
| − | {{tp|p=32356516|t=2020. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.|pdf=|usr=007}}
| |
| − | {{tp|p=32484776|t=2020. COVID-19 and obstructive sleep apnea.|pdf=|usr=007}}
| |
| − | {{tp|p=32347205|t=2020. Narcolepsy and COVID-19: sleeping on an opportunity?|pdf=|usr=007}}
| |
| − | {{tp|p=32449619|t=2020. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.|pdf=|usr=007}}
| |
| − | {{tp|p=32464084|t=2020. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32415815|t=2020. Lessons Learned from COVID-19 Pandemic in Italy.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32454503|t=2020. Stroke in COVID-19 and SARS-CoV-1.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32508037|t=2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32508024|t=2020. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32508041|t=2020. Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.|pdf=|usr=007}}
| |
| − | {{tp|p=32507407|t=2020. COVID 19-An eye on the virus.|pdf=|usr=007}}
| |
| − | {{tp|p=32505211|t=2020. Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32505652|t=2020. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32505980|t=2020. Relationship between COVID-19 and obesity.|pdf=|usr=007}}
| |
| − | {{tp|p=32469464|t=2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32463179|t=2020. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study.|pdf=|usr=007}}
| |
| − | {{tp|p=32463166|t=2020. Why is hyperglycemia worsening COVID-19 and its prognosis?|pdf=|usr=007}}
| |
| − | {{tp|p=32451317|t=2020. The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32506222|t=2020. COVID-19: Impact of and on Diabetes.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32438449|t=2020. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32507518|t=2020. Does active smoking worsen Covid-19?|pdf=|usr=007}}
| |
| − | {{tp|p=32460417|t=2020. COVID-19 - neurologists stay aware!|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32505514|t=2020. COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas.|pdf=|usr=007}}
| |
| − | {{tp|p=32504135|t=2020. Point-of-care lung ultrasound in three neonates with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32339038|t=2020. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.|pdf=|usr=007}}
| |
| − | {{tp|p=32500721|t=2020. Approach to Acute Cardiovascular Complications in COVID-19 Infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32482087|t=2020. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32386189|t=2020. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32386188|t=2020. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32423908|t=2020. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.|pdf=|usr=007}}
| |
| − | {{tp|p=32390405|t=2020. COVID-19 Viral Load of an Infected Family in China.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32414711|t=2020. The renin-angiotensin system - a therapeutic target in COVID-19?|pdf=|usr=007}}
| |
| − | {{tp|p=32462940|t=2020. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.|pdf=|usr=007}}
| |
| − | {{tp|p=32468411|t=2020. COVID-19 and Asthma: Reflection During the Pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32507883|t=2020. Covid-19: the renin-angiotensin system imbalance hypothesis.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32463005|t=2020. The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.|pdf=|usr=007}}
| |
| − | {{tp|p=32442082|t=2020. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.|pdf=|usr=007}}
| |
| − | {{tp|p=32448405|t=2020. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.|pdf=|usr=007}}
| |
| − | {{tp|p=32475056|t=2020. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32474988|t=2020. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.|pdf=|usr=007}}
| |
| − | {{tp|p=32406078|t=2020. COVID-19 in an elderly patient treated with secukinumab.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32478942|t=2020. Covid-19 infection in psoriasis patients treated with cyclosporin.|pdf=|usr=007}}
| |
| − | {{tp|p=32430456|t=2020. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?|pdf=|usr=007}}
| |
| − | {{tp|p=32409505|t=2020. COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.|pdf=|usr=007}}
| |
| − | {{tp|p=32409504|t=2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.|pdf=|usr=007}}
| |
| − | {{tp|p=32409502|t=2020. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32409499|t=2020. Obesity Is a Risk Factor for Greater COVID-19 Severity.|pdf=|usr=007}}
| |
| − | {{tp|p=32409498|t=2020. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.|pdf=|usr=007}}
| |
| − | {{tp|p=32496012|t=2020. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32482296|t=2020. COVID-19: Perspectives from people with diabetes.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32423922|t=2020. More advice on the use of ibuprofen for COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32468357|t=2020. An unresponsive COVID-19 patient.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32432700|t=2020. Return to sports after COVID-19 infection.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32498076|t=2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32449762|t=2020. Acute coronary syndromes during COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32432723|t=2020. Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.|pdf=|usr=007}}
| |
| − | {{tp|p=32432704|t=2020. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32464637|t=2020. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.|pdf=|usr=007}}
| |
| − | {{tp|p=32501480|t=2020. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.|pdf=|usr=007}}
| |
| − | {{tp|p=32501477|t=2020. Antihypertensive drugs in COVID-19 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32511752|t=2020. COVID-19 and End Stage Renal Disease.|pdf=|usr=007}}
| |
| − | {{tp|p=32511751|t=2020. SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids.|pdf=|usr=007}}
| |
| − | {{tp|p=32469251|t=2020. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?|pdf=|usr=007}}
| |
| − | {{tp|p=32453009|t=2020. Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32282549|t=2020. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32485082|t=2020. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32470281|t=2020. La bronquiolitis en el ano del COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32505489|t=2020. ROLE OF REHABILITATION DEPARTMENT FOR ADULT COVID-19 PATIENTS: THE EXPERIENCE OF THE SAN RAFFAELE HOSPITAL OF MILAN.|pdf=|usr=007}}
| |
| − | {{tp|p=32401850|t=2020. Coronavirus e o Coracao | Um Relato de Caso sobre a Evolucao da COVID-19 Associado a Evolucao Cardiologica.|pdf=|usr=007}}
| |
| − | {{tp|p=32401847|t=2020. O Coracao e a COVID-19: O que o Cardiologista Precisa Saber.|pdf=|usr=007}}
| |
| − | {{tp|p=32401844|t=2020. COVID-19: Dados Atualizados e sua Relacao Com o Sistema Cardiovascular.|pdf=|usr=007}}
| |
| − | {{tp|p=32491075|t=2020. Implicacoes Cardiovasculares em Pacientes Infectados com Covid-19 e a Importancia do Isolamento Social para Reduzir a Disseminacao da Doenca.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32491073|t=2020. O Efeito da Doenca de Coronavirus 2019 nas Doencas Cardiovasculares.|pdf=|usr=007}}
| |
| − | {{tp|p=32386125|t=2020. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.|pdf=|usr=007}}
| |
| − | {{tp|p=32458534|t=2020. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.|pdf=|usr=007}}
| |
| − | {{tp|p=32472827|t=2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.|pdf=|usr=007}}
| |
| − | {{tp|p=32512532|t=2020. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32471884|t=2020. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.|pdf=|usr=007}}
| |
| − | {{tp|p=32467124|t=2020. 80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32503812|t=2020. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32469077|t=2020. Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32438482|t=2020. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32420611|t=2020. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.|pdf=|usr=007}}
| |
| − | {{tp|p=32420609|t=2020. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32420608|t=2020. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.|pdf=|usr=007}}
| |
| − | {{tp|p=32452530|t=2020. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32408910|t=2020. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.|pdf=|usr=007}}
| |
| − | {{tp|p=32470162|t=2020. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32427288|t=2020. ACE2 Receptor Expression in Testes: Implications in COVID-19 Pathogenesis.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32444450|t=2020. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.|pdf=|usr=007}}
| |
| − | {{tp|p=32422078|t=2020. Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32338533|t=2020. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.|pdf=|usr=007}}
| |
| − | {{tp|p=32320546|t=2020. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.|pdf=|usr=007}}
| |
| − | {{tp|p=32506699|t=2020. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?|pdf=|usr=007}}
| |
| − | {{tp|p=32475091|t=2020. Cardiovascular conditions and COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32376670|t=2020. Covid-19: the challenge of patient rehabilitation after intensive care.|pdf=|usr=007}}
| |
| − | {{tp|p=32366505|t=2020. Covid-19 and pregnancy.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32434891|t=2020. Covid-19 and cardiovascular disease.|pdf=|usr=007}}
| |
| − | {{tp|p=32398229|t=2020. Covid-19: Low skilled men have highest death rate of working age adults.|pdf=|usr=007}}
| |
| − | {{tp|p=32393504|t=2020. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities.|pdf=|usr=007}}
| |
| − | {{tp|p=32357954|t=2020. Covid-19 is no worse in immunocompromised children, says NICE.|pdf=|usr=007}}
| |
| − | {{tp|p=32217618|t=2020. Covid-19: risk factors for severe disease and death.|pdf=|usr=007}}
| |
| − | {{tp|p=32213482|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=007}}
| |
| − | {{tp|p=32209544|t=2020. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.|pdf=|usr=007}}
| |
| − | {{tp|p=32327432|t=2020. Covid-19: Doctors should be alert for signs of myocardial injury, says NICE.|pdf=|usr=007}}
| |
| − | {{tp|p=32291260|t=2020. Covid-19: Nine in 10 pregnant women with infection when admitted for delivery are asymptomatic, small study finds.|pdf=|usr=007}}
| |
| − | {{tp|p=32303575|t=2020. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.|pdf=|usr=007}}
| |
| − | {{tp|p=32467101|t=2020. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.|pdf=|usr=007}}
| |
| − | {{tp|p=32378464|t=2020. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19).|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32484906|t=2020. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32479664|t=2020. A Case Series of MGUS and COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32475821|t=2020. The Stanford Hall consensus statement for post-COVID-19 rehabilitation.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32311273|t=2020. Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32493522|t=2020. The impact of the Covid-19 Pandemic on Stroke Volume.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32471876|t=2020. Registries Offer Insights on COVID-19-Cancer Connection.|pdf=|usr=007}}
| |
| − | {{tp|p=32398243|t=2020. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.|pdf=|usr=007}}
| |
| − | {{tp|p=32427636|t=2020. ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?|pdf=|usr=007}}
| |
| − | {{tp|p=32496364|t=2020. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?|pdf=|usr=007}}
| |
| − | {{tp|p=32427637|t=2020. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32209890|t=2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.|pdf=|usr=007}}
| |
| − | {{tp|p=32432519|t=2020. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?|pdf=|usr=007}}
| |
| − | {{tp|p=32511019|t=2020. COVID-19 infection at nighttime.|pdf=|usr=007}}
| |
| − | {{tp|p=32498625|t=2020. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32473009|t=2020. Age-dependent gender differences of COVID-19 in mainland China: comparative study.|pdf=|usr=007}}
| |
| − | {{tp|p=32472683|t=2020. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
| |
| − | {{tp|p=32472676|t=2020. Predictors for Severe COVID-19 Infection.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32444880|t=2020. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.|pdf=|usr=007}}
| |
| − | {{tp|p=32442294|t=2020. Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32442285|t=2020. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.|pdf=|usr=007}}
| |
| − | {{tp|p=32442265|t=2020. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.|pdf=|usr=007}}
| |
| − | {{tp|p=32442259|t=2020. Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?|pdf=|usr=007}}
| |
| − | {{tp|p=32433729|t=2020. Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.|pdf=|usr=007}}
| |
| − | {{tp|p=32211755|t=2020. Epidemiological and Clinical Predictors of COVID-19.|pdf=|usr=007}}
| |
| − | {{ttp|p=32502247|t=2020. Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?|pdf=|usr=007}}
| |
| − | {{tp|p=32444393|t=2020. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32441332|t=2020. Clinical course of coronavirus disease-2019 in pregnancy.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32470948|t=2020. Why does COVID-19 disproportionately affect older people?|pdf=|usr=007}}
| |
| − | {{tp|p=32499448|t=2020. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32496339|t=2020. Lipase Elevation in Patients With COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32483005|t=2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32512038|t=2020. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.|pdf=|usr=007}}
| |
| − | {{tp|p=32459524|t=2020. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32491949|t=2020. Understanding the age divide in COVID-19: Why are children overwhelmingly spared?|pdf=|usr=007}}
| |
| − | {{tp|p=32432918|t=2020. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.|pdf=|usr=007}}
| |
| − | {{tp|p=32401670|t=2020. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32436646|t=2020. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience.|pdf=|usr=007}}
| |
| − | {{tp|p=32503857|t=2020. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.|pdf=|usr=007}}
| |
| − | {{tp|p=32469504|t=2020. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32420961|t=2020. Report of a series of healthy term newborns from convalescent mothers with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32420955|t=2020. Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32420950|t=2020. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.|pdf=|usr=007}}
| |
| − | {{tp|p=32420949|t=2020. Rare Anaemias, Sickle-Cell Disease and COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32420948|t=2020. SARS-CoV-2 infection in children in Parma.|pdf=|usr=007}}
| |
| − | {{tp|p=32420942|t=2020. COVID19: potential cardiovascular issues in pediatric patients.|pdf=|usr=007}}
| |
| − | {{tp|p=32420941|t=2020. Novel coronavirus infection and children.|pdf=|usr=007}}
| |
| − | {{tp|p=32420939|t=2020. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.|pdf=|usr=007}}
| |
| − | {{tp|p=32420934|t=2020. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.|pdf=|usr=007}}
| |
| − | {{tp|p=32420930|t=2020. Primum non nocere. The SARS-CoV-2 pandemic course in oldest.|pdf=|usr=007}}
| |
| − | {{tp|p=32420925|t=2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?|pdf=|usr=007}}
| |
| − | {{tp|p=32474914|t=2020. Anxiety and depression levels among pregnant women with COVID-19.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32470131|t=2020. The COVID-19 Rehabilitation Pandemic.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32508193|t=2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32511678|t=2020. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.|pdf=|usr=007}}
| |
| − | {{tp|p=32380565|t=2020. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?|pdf=|usr=007}}
| |
| − | {{tp|p=32438425|t=2020. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.|pdf=|usr=007}}
| |
| − | {{tp|p=32428964|t=2020. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32403141|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.|pdf=|usr=007}}
| |
| − | {{tp|p=32503058|t=2020. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?|pdf=|usr=007}}
| |
| − | {{tp|p=32467494|t=2020. In response to: Simpson R and Robinson L: Rehabilitation following critical illness in people with COVID-19 infection.|pdf=|usr=007}}
| |
| − | {{tp|p=32467490|t=2020. The place of early rehabilitation in ICU for Covid-19.|pdf=|usr=007}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32471004|t=2020. Early COVID-19 infection after lung transplantation.|pdf=|usr=007}}
| |
| − | {{tp|p=32471001|t=2020. COVID-19 in elderly kidney transplant recipients.|pdf=|usr=007}}
| |
| − | {{tp|p=32492753|t=2020. Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.|pdf=|usr=007}}
| |
| − | {{tp|p=32483909|t=2020. Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.|pdf=|usr=007}}
| |
| − | {{tp|p=32476258|t=2020. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32431287|t=2020. Critical Care Management of Patients with COVID-19: Early Experience in Thailand.|pdf=|usr=007}}
| |
| − | {{tp|p=32419694|t=2020. Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32503849|t=2020. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.|pdf=|usr=007}}
| |
| − | {{tp|p=32503848|t=2020. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.|pdf=|usr=007}}
| |
| − | {{tp|p=32205336|t=2020. Are my patients with rheumatic diseases at higher risk of COVID-19?|pdf=|usr=007}}
| |
| − | {{tp|p=32354774|t=2020. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.|pdf=|usr=007}}
| |
| − | {{tp|p=32354773|t=2020. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.|pdf=|usr=007}}
| |
| − | {{tp|p=32321723|t=2020. What is the true incidence of COVID-19 in patients with rheumatic diseases?|pdf=|usr=007}}
| |
| − | ===008===weiter dann
| |
| − |
| |
| − |
| |
| − | {{tp|p=32451362|t=2020. Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32425272|t=2020. Early manifestation of ARDS in COVID-19 infection in a 51- year-old man affected by Mounier-Kuhn Syndrome.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32457005|t=2020. Flattening the disability curve: Rehabilitation and recovery after COVID-19 infection.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32450334|t=2020. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32440857|t=2020. Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.|pdf=|usr=008}}
| |
| − | {{tp|p=32386449|t=2020. Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.|pdf=|usr=008}}
| |
| − | {{tp|p=32359177|t=2020. Longitudinal association between markers of liver injury and mortality in COVID-19 in China.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32527699|t=2020. El SRAA y el SARS-CoV-2: el acertijo a resolver.|pdf=|usr=008}}
| |
| − | {{tp|p=32451303|t=2020. Hipertension y COVID-19: cuidados con los manguitos de presion arterial.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32439915|t=2020. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?|pdf=|usr=008}}
| |
| − | {{tp|p=32523133|t=2020. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.|pdf=|usr=008}}
| |
| − | {{tp|p=32483311|t=2020. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.|pdf=|usr=008}}
| |
| − | {{tp|p=32436403|t=2020. Evidence That Renin-Angiotensin System Inhibitors Should Not Be Discontinued Due to the COVID-19 Pandemic.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32461911|t=2020. Progression of CXR features on a COVID-19 survivor.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32457811|t=2020. The lethal sex gap: COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32473971|t=2020. Are there any association between COVID-19 severity and immunosuppressive therapy?|pdf=|usr=008}}
| |
| − | {{tp|p=32489118|t=2020. Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors.|pdf=|usr=008}}
| |
| − | {{tp|p=32405087|t=2020. Continue ACE inhibitors/ ARB'S till further evidence in Coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32405088|t=2020. Cardiological society of India position statement on COVID-19 and heart failure.|pdf=|usr=008}}
| |
| − | {{tp|p=32317806|t=2020. Carpal Fracture and COVID-19 Infection: Observation from Thailand.|pdf=|usr=008}}
| |
| − | {{tp|p=32410003|t=2020. Pathophysiology of COVID-19: Why Children Fare Better than Adults?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32504454|t=2020. Manifestations in Neonates Born to COVID-19 Positive Mothers.|pdf=|usr=008}}
| |
| − | {{tp|p=32495219|t=2020. Clinical Features and Treatment Protocol in Eleven Chinese Children with Mild COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32370577|t=2020. Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32462545|t=2020. Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32415334|t=2020. Recurrence of COVID-19 after recovery: a case report from Italy.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32394344|t=2020. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32390091|t=2020. Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32532944|t=2020. Prognosis of COVID-19: Changes in laboratory parameters.|pdf=|usr=008}}
| |
| − | {{tp|p=32532943|t=2020. Differences among confirmed and not-confirmed COVID-19 patients at "D.Cotugno" hospital, Naples (Italy): what we learned from first suspected cases?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32532938|t=2020. COVID-19 and pregnancy: a review of current knowledge.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32397011|t=2020. Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.|pdf=|usr=008}}
| |
| − | {{tp|p=32516795|t=2020. Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.|pdf=|usr=008}}
| |
| − | {{tp|p=32418736|t=2020. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32425514|t=2020. Covid-19 and COPD: A Personal Reflection.|pdf=|usr=008}}
| |
| − | {{tp|p=32410206|t=2020. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32266754|t=2020. COVID-19: Risk groups, mechanistic insights and challenges.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32492533|t=2020. Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32470606|t=2020. Clinical Characteristics of Critically Ill Patients Co-infected with SARS-CoV-2 and the Influenza Virus in Wuhan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32464272|t=2020. Uganda's First 100 COVID-19 Cases: Trends and Lessons.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32417248|t=2020. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian seven-week-old suckling baby.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32535301|t=2020. Comparison of Hospitalized Patients with pneumonia caused by COVID-19 and influenza A in children under 5 years.|pdf=|usr=008}}
| |
| − | {{tp|p=32497798|t=2020. A Follow-up Study of Recovered Patients with COVID-19 in Wuhan, China.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32335337|t=2020. Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity.|pdf=|usr=008}}
| |
| − | {{tp|p=32444771|t=2020. Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32514077|t=2020. COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity.|pdf=|usr=008}}
| |
| − | {{tp|p=32480136|t=2020. Asymptomatic COVID-19 infection in a child with nasal foreign body.|pdf=|usr=008}}
| |
| − | {{tp|p=32451563|t=2020. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32458212|t=2020. Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City.|pdf=|usr=008}}
| |
| − | {{tp|p=32451579|t=2020. The baby lung and the COVID-19 era.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32385628|t=2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?|pdf=|usr=008}}
| |
| − | {{tp|p=32474850|t=2020. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32430652|t=2020. COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.|pdf=|usr=008}}
| |
| − | {{tp|p=32424634|t=2020. Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32514683|t=2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32470485|t=2020. Does asthma affect morbidity or severity of Covid-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32450087|t=2020. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32417136|t=2020. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab.|pdf=|usr=008}}
| |
| − | {{tp|p=32417445|t=2020. Asthma prolongs intubation in COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32405123|t=2020. Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32470515|t=2020. Ramipril in High Risk Patients with COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32383778|t=2020. A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32383809|t=2020. Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.|pdf=|usr=008}}
| |
| − | {{tp|p=32329525|t=2020. Characteristics and Palliative Care Needs of COVID-19 Patients Receiving Comfort-Directed Care.|pdf=|usr=008}}
| |
| − | {{tp|p=32379114|t=2020. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32417380|t=2020. Coronavirus Disease-2019 in Heart Transplant Recipients in Southeastern Michigan: A Case Series.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32439095|t=2020. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32400044|t=2020. The importance of repeat testing in detecting coronavirus disease 2019 (COVID-19) in a coronary artery bypass grafting patient.|pdf=|usr=008}}
| |
| − | {{tp|p=32340070|t=2020. ACE inhibitors and COVID-19: We don't know yet.|pdf=|usr=008}}
| |
| − | {{tp|p=32474332|t=2020. Tetralogy of Fallot palliation in a COVID-19 positive neonate.|pdf=|usr=008}}
| |
| − | {{tp|p=32450473|t=2020. Elevated cardiac biomarkers are associated with increased mortality for inpatients with COVID-19: A retrospective case-control study.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32516940|t=2020. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.|pdf=|usr=008}}
| |
| − | {{tp|p=32512688|t=2020. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe.|pdf=|usr=008}}
| |
| − | {{tp|p=32489501|t=2020. Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32412150|t=2020. COVID-19 and Indigenous Peoples: An imperative for action.|pdf=|usr=008}}
| |
| − | {{tp|p=32485619|t=2020. Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study.|pdf=|usr=008}}
| |
| − | {{tp|p=32278300|t=2020. Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32361327|t=2020. Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32361323|t=2020. Clinical features of pediatric patients with coronavirus disease (COVID-19).|pdf=|usr=008}}
| |
| − | {{tp|p=32311650|t=2020. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32305882|t=2020. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.|pdf=|usr=008}}
| |
| − | {{tp|p=32454427|t=2020. Children are protected against SARS-CoV-2 infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32447256|t=2020. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes.|pdf=|usr=008}}
| |
| − | {{tp|p=32434708|t=2020. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32425663|t=2020. Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2.|pdf=|usr=008}}
| |
| − | {{tp|p=32417675|t=2020. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32333494|t=2020. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32402680|t=2020. COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32521120|t=2020. Does glycemic control rescue type 2 diabetic patients from COVID-19-related deaths?|pdf=|usr=008}}
| |
| − | {{tp|p=32509886|t=2020. Novel coronavirus disease 2019 and perinatal outcomes.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32386431|t=2020. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32414666|t=2020. A severe-type COVID-19 case with prolonged virus shedding.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32410276|t=2020. RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32530994|t=2020. COVID-19 in a Patient with Liver Cirrhosis.|pdf=|usr=008}}
| |
| − | {{tp|p=32530989|t=2020. Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32519326|t=2020. Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32495088|t=2020. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32362394|t=2020. First cases of COVID-19 in heart transplantation from China.|pdf=|usr=008}}
| |
| − | {{tp|p=32362390|t=2020. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.|pdf=|usr=008}}
| |
| − | {{tp|p=32253113|t=2020. COVID-19: Yet another coronavirus challenge in transplantation.|pdf=|usr=008}}
| |
| − | {{tp|p=32340870|t=2020. COVID-19 in a lung transplant recipient.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32522278|t=2020. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32473194|t=2020. Liver tests abnormalities in COVID-19: trick or treat?|pdf=|usr=008}}
| |
| − | {{tp|p=32446714|t=2020. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.|pdf=|usr=008}}
| |
| − | {{tp|p=32445883|t=2020. Lack of genetic evidence that fatty liver disease predisposes to COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32437831|t=2020. Reply to: 'Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis'.|pdf=|usr=008}}
| |
| − | {{tp|p=32526252|t=2020. High rates of 30-day mortality in patients with cirrhosis and COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32434789|t=2020. Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy.|pdf=|usr=008}}
| |
| − | {{tp|p=32423535|t=2020. Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32371823|t=2020. Respiratory Distress in Postanesthesia Care Unit: First Presentation of Coronavirus Disease 2019 in a 17-Year-Old Girl: A Case Report.|pdf=|usr=008}}
| |
| − | {{tp|p=32516467|t=2020. Testing Asymptomatic Emergency Department Patients for Coronavirus of 2019 (COVID-19) in a Low Prevalence Region.|pdf=|usr=008}}
| |
| − | {{tp|p=32344458|t=2020. Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32418781|t=2020. COVID-19 and Gynecomastia: What is the Relationship?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32425432|t=2020. Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32444942|t=2020. Are patients with Down syndrome vulnerable to life-threatening COVID-19?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32386441|t=2020. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden.|pdf=|usr=008}}
| |
| − | {{tp|p=32386440|t=2020. Severe maternal morbidity and mortality associated with COVID-19: The risk should not be downplayed.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32521068|t=2020. COVID-19 is milder in children possibly due to cross immunity.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32395673|t=2020. Clinical and Radiographic Presentations of COVID-19 among Patients Receiving Radiation Therapy for Thoracic Malignancies.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32458356|t=2020. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.|pdf=|usr=008}}
| |
| − | {{tp|p=32390064|t=2020. COVID-19 in older adults.|pdf=|usr=008}}
| |
| − | {{tp|p=32489711|t=2020. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32509416|t=2020. Acute Respiratory Decompensation Requiring Intubation in Pregnant Women with SARS-CoV-2 (COVID-19).|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32400858|t=2020. Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32406119|t=2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32406090|t=2020. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.|pdf=|usr=008}}
| |
| − | {{tp|p=32455491|t=2020. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32506509|t=2020. Clinical characteristics of COVID-19 patients combined with allergy.|pdf=|usr=008}}
| |
| − | {{tp|p=32524611|t=2020. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.|pdf=|usr=008}}
| |
| − | {{tp|p=32479648|t=2020. Is asthma protective against COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32498691|t=2020. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.|pdf=|usr=008}}
| |
| − | {{tp|p=32512291|t=2020. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32502882|t=2020. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32414525|t=2020. COVID-19 in healthcare workers.|pdf=|usr=008}}
| |
| − | {{tp|p=32386808|t=2020. Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32475761|t=2020. Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32444295|t=2020. Atypical presentation of COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32427676|t=2020. Shanghai Zhongshan Experience on Digestive Endoscopic Procedures During 2020 COVID-19 Pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32519406|t=2020. Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.|pdf=|usr=008}}
| |
| − | {{tp|p=32515085|t=2020. COVID-19 in recent kidney transplant recipients.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32524732|t=2020. Worse progression of COVID-19 in men: Is Testosterone a key factor?|pdf=|usr=008}}
| |
| − | {{tp|p=32520728|t=2020. Anesthesiologists' and intensive care providers' exposure to COVID-19 infection in a New York City academic center: a prospective cohort study assessing symptoms and COVID-19 antibody testing.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32444415|t=2020. Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32471903|t=2020. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.|pdf=|usr=008}}
| |
| − | {{tp|p=32439956|t=2020. Management of newborns exposed to mothers with confirmed or suspected COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32474140|t=2020. Maternal choline and respiratory coronavirus effects on fetal brain development.|pdf=|usr=008}}
| |
| − | {{tp|p=32434431|t=2020. Cardiovascular disease, heart failure and COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32408793|t=2020. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.|pdf=|usr=008}}
| |
| − | {{tp|p=32403977|t=2020. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?|pdf=|usr=008}}
| |
| − | {{tp|p=32362035|t=2020. Treating COVID-19 in Rural America.|pdf=|usr=008}}
| |
| − | {{tp|p=32396220|t=2020. Unequal Distribution of COVID-19 Risk among Rural Residents by Race and Ethnicity.|pdf=|usr=008}}
| |
| − | {{tp|p=32282964|t=2020. A Commentary on Rural-Urban Disparities in COVID-19 Testing Rates per 100,000 and Risk Factors.|pdf=|usr=008}}
| |
| − | {{tp|p=32277775|t=2020. Caring for Miners During the Coronavirus Disease-2019 (COVID-19) Pandemic.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32352913|t=2020. Cesarean Section in a Pregnant Woman with COVID-19: First Case in Portugal.|pdf=|usr=008}}
| |
| − | {{tp|p=32533756|t=2020. Physiological advantages of children against COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32533572|t=2020. COVID-19 and Down syndrome.|pdf=|usr=008}}
| |
| − | {{tp|p=32239761|t=2020. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32412919|t=2020. Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32531620|t=2020. Pediatric COVID-19: Systematic review of the literature.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32530714|t=2020. Cigarette Smoking and COVID-19: A Complex Interaction.|pdf=|usr=008}}
| |
| − | {{tp|p=32530707|t=2020. Reply to: Cigarette Smoking and COVID-19: A Complex Interaction.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32381561|t=2020. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32475835|t=2020. Patients with lupus with COVID-19: University of Michigan experience.|pdf=|usr=008}}
| |
| − | {{tp|p=32475834|t=2020. Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.|pdf=|usr=008}}
| |
| − | {{tp|p=32475832|t=2020. Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al.|pdf=|usr=008}}
| |
| − | {{tp|p=32475831|t=2020. Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.|pdf=|usr=008}}
| |
| − | {{tp|p=32471900|t=2020. Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32471898|t=2020. Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32457048|t=2020. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.|pdf=|usr=008}}
| |
| − | {{tp|p=32451345|t=2020. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.|pdf=|usr=008}}
| |
| − | {{tp|p=32451344|t=2020. Are patients with systemic lupus erythematosus at increased risk for COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32434823|t=2020. Rheumatic diseases in intensive care unit patients with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32467245|t=2020. Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32415836|t=2020. Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?|pdf=|usr=008}}
| |
| − | {{tp|p=32415832|t=2020. COVID-19 and ACEI/ARB: NOT ASSOCIATED?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32460973|t=2020. Age-related difference in the rate of COVID-19 mortality in women versus men.|pdf=|usr=008}}
| |
| − | {{tp|p=32439389|t=2020. Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State.|pdf=|usr=008}}
| |
| − | {{tp|p=32391520|t=2020. Placental abruption in a twin pregnancy at 32 weeks' gestation complicated by COVID-19, without vertical transmission to the babies.|pdf=|usr=008}}
| |
| − | {{tp|p=32391519|t=2020. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32518902|t=2020. Coronavirus disease 2019 in pregnancy: early lessons.|pdf=|usr=008}}
| |
| − | {{tp|p=32437114|t=2020. Early Rehabilitation for Critically Ill Patients With COVID-19: More Benefits Than Risks.|pdf=|usr=008}}
| |
| − | {{tp|p=32228322|t=2020. COVID-19 pandemic, coronaviruses, and diabetes mellitus.|pdf=|usr=008}}
| |
| − | {{tp|p=32315543|t=2020. An Asymptomatic Patient with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32369262|t=2020. Kidney transplantation with presymptomatic COVID-19-positive surgeon.|pdf=|usr=008}}
| |
| − | {{tp|p=32412159|t=2020. First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study.|pdf=|usr=008}}
| |
| − | {{tp|p=32406181|t=2020. Mild COVID-19 in a pediatric renal transplant recipient.|pdf=|usr=008}}
| |
| − | {{tp|p=32400965|t=2020. Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.|pdf=|usr=008}}
| |
| − | {{tp|p=32400931|t=2020. Viral shedding prolongation in a kidney transplant patient with COVID-19 pneumonia.|pdf=|usr=008}}
| |
| − | {{tp|p=32400099|t=2020. Novel Corona Virus 2019 pneumonia in a kidney transplant recipient.|pdf=|usr=008}}
| |
| − | {{tp|p=32400084|t=2020. SARS-CoV-2 infection in two patients following recent lung transplantation.|pdf=|usr=008}}
| |
| − | {{tp|p=32400074|t=2020. COVID-19 pneumonia in lung transplant recipients: Report of 2 cases.|pdf=|usr=008}}
| |
| − | {{tp|p=32400013|t=2020. A case of coronavirus disease 2019-infected liver transplant donor.|pdf=|usr=008}}
| |
| − | {{tp|p=32314685|t=2020. Case Report: The First Case of COVID-19 in Bhutan.|pdf=|usr=008}}
| |
| − | {{tp|p=32452644|t=2020. Caution in the management of SARS-CoV-2 infection in males.|pdf=|usr=008}}
| |
| − | {{tp|p=32436355|t=2020. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32357288|t=2020. SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.|pdf=|usr=008}}
| |
| − | {{tp|p=32472773|t=2020. A COVID-19 Conundrum: Obstructive Sleep Apnea (OSA) and Non-Invasive Ventilation (NIV).|pdf=|usr=008}}
| |
| − | {{tp|p=32413342|t=2020. COVID-19 in diabetic patients: Related risks and specifics of management.|pdf=|usr=008}}
| |
| − | {{tp|p=32419766|t=2020. Assessing Differential Impacts of COVID-19 on Black Communities.|pdf=|usr=008}}
| |
| − | {{tp|p=32419765|t=2020. Understanding COVID-19 Risks and Vulnerabilities among Black Communities in America: The Lethal Force of Syndemics.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32422077|t=2020. COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy.|pdf=|usr=008}}
| |
| − | {{tp|p=32422062|t=2020. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.|pdf=|usr=008}}
| |
| − | {{tp|p=32491919|t=2020. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review.|pdf=|usr=008}}
| |
| − | {{tp|p=32383812|t=2020. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32418848|t=2020. Early mobilization in hospitalized patients with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32434818|t=2020. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al.|pdf=|usr=008}}
| |
| − | {{tp|p=32532753|t=2020. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32411770|t=2020. Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32395487|t=2020. Clinical characteristics of Coronavirus Disease 2019 and development of a prediction model for prolonged hospital length of stay.|pdf=|usr=008}}
| |
| − | {{tp|p=32395474|t=2020. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.|pdf=|usr=008}}
| |
| − | {{tp|p=32440661|t=2020. Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review.|pdf=|usr=008}}
| |
| − | {{tp|p=32440660|t=2020. Analysis of Maternal Coronavirus Infections and Neonates Born to Mothers with 2019-nCoV; a Systematic Review.|pdf=|usr=008}}
| |
| − | {{tp|p=32336565|t=2020. Situacion clinica de infeccion por SARS-CoV-2 en pacientes con carcinoma broncogenico: contexto actual.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32518045|t=2020. Severe and fatal forms of COVID-19 in children.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32526068|t=2020. Perspectives of patients with rheumatic diseases in the early phase of COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32304393|t=2020. Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32526039|t=2020. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32522306|t=2020. COVID-19 in adult patients with CHD: a matter of anatomy or comorbidities?|pdf=|usr=008}}
| |
| − | {{tp|p=32414805|t=2020. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.|pdf=|usr=008}}
| |
| − | {{tp|p=32414804|t=2020. COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.|pdf=|usr=008}}
| |
| − | {{tp|p=32404341|t=2020. Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romao et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal.|pdf=|usr=008}}
| |
| − | {{tp|p=32404340|t=2020. No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: response to the comment by Joob and Wiwanitkit.|pdf=|usr=008}}
| |
| − | {{tp|p=32522741|t=2020. Biologics, spondylitis and COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32523145|t=2020. COVID-19 y el sistema renina, angiotensina, aldosterona. Una relacion compleja.|pdf=|usr=008}}
| |
| − | {{tp|p=32523141|t=2020. Infeccion por coronavirus en pacientes con diabetes.|pdf=|usr=008}}
| |
| − | {{tp|p=32523139|t=2020. Recomendaciones para la atencion de pacientes con insuficiencia cardiaca y COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32531146|t=2020. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32220899|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=008}}
| |
| − | {{tp|p=32532739|t=2020. Covid-19: People in most deprived areas of England and Wales twice as likely to die.|pdf=|usr=008}}
| |
| − | {{tp|p=32532737|t=2020. Covid-19: Government will belatedly publish recommendations for protecting ethnic minorities.|pdf=|usr=008}}
| |
| − | {{tp|p=32527762|t=2020. Risks to Bangladeshi children and young people during covid-19 outbreak.|pdf=|usr=008}}
| |
| − | {{tp|p=32527732|t=2020. Ethnicity and covid-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32522740|t=2020. Obesity and covid-19: the role of the food industry.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32354809|t=2020. Managing patients with COVID-19 infections: a first-hand experience from the Wuhan Mobile Cabin Hospital.|pdf=|usr=008}}
| |
| − | {{tp|p=32532764|t=2020. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32522556|t=2020. The impact of asthma on mortality in COVID-19 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32519912|t=2020. Effects of altered photoperiod due to COVID-19 lockdown on pregnant women and their fetuses.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32527466|t=2020. SARS-CoV-2 as a protective factor for cardiovascular mortality?|pdf=|usr=008}}
| |
| − | {{tp|p=32294229|t=2020. COVID-19 vaginal delivery - A case report.|pdf=|usr=008}}
| |
| − | {{tp|p=32513532|t=2020. Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke.|pdf=|usr=008}}
| |
| − | {{tp|p=32450906|t=2020. Impact of sex and gender on COVID-19 outcomes in Europe.|pdf=|usr=008}}
| |
| − | {{tp|p=32426991|t=2020. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.|pdf=|usr=008}}
| |
| − | {{tp|p=32490680|t=2020. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32428835|t=2020. Advances in the relationship between coronavirus infection and cardiovascular diseases.|pdf=|usr=008}}
| |
| − | {{tp|p=32362005|t=2020. Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32381073|t=2020. A child with household transmitted COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32460871|t=2020. Diagnosis of COVID-19 in children: the story evolves.|pdf=|usr=008}}
| |
| − | {{tp|p=32517687|t=2020. COVID-19 cancer conundrum-evidence driving decisions or the lack of it?|pdf=|usr=008}}
| |
| − | {{tp|p=32493370|t=2020. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.|pdf=|usr=008}}
| |
| − | {{tp|p=32444460|t=2020. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32444366|t=2020. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32409488|t=2020. Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study.|pdf=|usr=008}}
| |
| − | {{tp|p=32513659|t=2020. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32385047|t=2020. Off the back burner: diverse and gender-inclusive decision-making for COVID-19 response and recovery.|pdf=|usr=008}}
| |
| − | {{tp|p=32532758|t=2020. Hypothesis to explain the severe form of COVID-19 in Northern Italy.|pdf=|usr=008}}
| |
| − | {{tp|p=32513864|t=2020. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest.|pdf=|usr=008}}
| |
| − | {{tp|p=32455170|t=2020. Understanding COVID-19 in children may provide clues to protect at-risk populations.|pdf=|usr=008}}
| |
| − | {{tp|p=32499538|t=2020. Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32528121|t=2020. Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.|pdf=|usr=008}}
| |
| − | {{tp|p=32483288|t=2020. Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32534738|t=2020. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies.|pdf=|usr=008}}
| |
| − | {{tp|p=32534737|t=2020. COVID-19 and improved prevention of hospital-acquired infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32439072|t=2020. Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea.|pdf=|usr=008}}
| |
| − | {{tp|p=32384171|t=2020. COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions.|pdf=|usr=008}}
| |
| − | {{tp|p=32348554|t=2020. Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32379921|t=2020. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.|pdf=|usr=008}}
| |
| − | {{tp|p=32379902|t=2020. COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32473945|t=2020. COVID-19, hypercoagulation and what it could mean for patients with psychotic disorders.|pdf=|usr=008}}
| |
| − | {{tp|p=32470593|t=2020. Can COVID-19 related mental health issues be measured?|pdf=|usr=008}}
| |
| − | {{tp|p=32464158|t=2020. Correlation between immune response and self-reported depression during convalescence from COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32464156|t=2020. Depression and anxiety among adolescents during COVID-19: A cross-sectional study.|pdf=|usr=008}}
| |
| − | {{tp|p=32416290|t=2020. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32454138|t=2020. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK.|pdf=|usr=008}}
| |
| − | {{tp|p=32479748|t=2020. Analysis of clinical and demographic heterogeneity of patients dying from COVID-19 in Brazil versus China and Italy.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32405915|t=2020. Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.|pdf=|usr=008}}
| |
| − | {{tp|p=32271625|t=2020. Should Infants Be Separated from Mothers with COVID-19? First, Do No Harm.|pdf=|usr=008}}
| |
| − | {{tp|p=32428080|t=2020. Vulnerabilidade a formas graves de COVID-19: uma analise intramunicipal na cidade do Rio de Janeiro, Brasil.|pdf=|usr=008}}
| |
| − | {{tp|p=32428076|t=2020. COVID-19 e tabagismo: uma relacao de risco.|pdf=|usr=008}}
| |
| − | {{tp|p=32404451|t=2020. Coronavirus disease 2019 in children: Surprising findings in the midst of a global pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32532719|t=2020. Symptom management and end-of-life care of residents with COVID-19 in long-term care homes.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32502522|t=2020. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.|pdf=|usr=008}}
| |
| − | {{tp|p=32494330|t=2020. Coronavirus Disease 2019 With Acute Respiratory Distress Syndrome Mimicking Heart Failure Exacerbation: Time to Rethink.|pdf=|usr=008}}
| |
| − | {{tp|p=32535705|t=2020. Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32515033|t=2020. Severity and risk of COVID-19 in cancer patients: An evidence based learning.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32526093|t=2020. Dermatological therapies with relevance to COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32517822|t=2020. Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32526060|t=2020. What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.|pdf=|usr=008}}
| |
| − | {{tp|p=32516861|t=2020. Clinical characteristics and prognostic factors in COVID-19 patients aged >/=80 years.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32535689|t=2020. Challenges in Neonatal COVID-19 Infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32535876|t=2020. Successful management of the first reported case in Austria of COVID-19 with ARDS.|pdf=|usr=008}}
| |
| − | {{tp|p=32525566|t=2020. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32522559|t=2020. Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32536009|t=2020. Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment".|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32503837|t=2020. Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.|pdf=|usr=008}}
| |
| − | {{tp|p=32533988|t=2020. COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research.|pdf=|usr=008}}
| |
| − | {{tp|p=32492745|t=2020. Kardiale Biomarker und COVID-19-Phanotypen und Interpretation.|pdf=|usr=008}}
| |
| − | {{tp|p=32378797|t=2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Initial results from the COVID-19 Emergency Department Quality Improvement Project (COVED-1).|pdf=|usr=008}}
| |
| − | {{tp|p=32533613|t=2020. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Results from the first month of the COVED Quality Improvement Project (COVED-2).|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32531040|t=2020. Association between renin-angiotensin system inhibitors and COVID-19 complications.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32535885|t=2020. High mortality in COVID-19 patients with mild respiratory disease.|pdf=|usr=008}}
| |
| − | {{tp|p=32531806|t=2020. Obesity, adipokines and COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32522810|t=2020. Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32525813|t=2020. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.|pdf=|usr=008}}
| |
| − | {{tp|p=32535573|t=2020. COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS.|pdf=|usr=008}}
| |
| − | {{tp|p=32436422|t=2020. Men and COVID-19: Adding a gender lens.|pdf=|usr=008}}
| |
| − | {{tp|p=32518091|t=2020. COVID-19: A UK Children's Hospital Experience.|pdf=|usr=008}}
| |
| − | {{tp|p=32530392|t=2020. The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study.|pdf=|usr=008}}
| |
| − | {{tp|p=32517835|t=2020. Delayed Recognition of Community Transmission of COVID-19 Resulting in Healthcare Worker Infections.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32393351|t=2020. Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32527257|t=2020. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32426242|t=2020. Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report.|pdf=|usr=008}}
| |
| − | {{tp|p=32523874|t=2020. Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: A case report.|pdf=|usr=008}}
| |
| − | {{tp|p=32385549|t=2020. COVID-19, Angiotensin Receptor Blockers, and the Brain.|pdf=|usr=008}}
| |
| − | {{tp|p=32501455|t=2020. Down Syndrome and COVID-19: A Perfect Storm?|pdf=|usr=008}}
| |
| − | {{tp|p=32405955|t=2020. Management of Patients with Cerebellar Ataxia During the COVID-19 Pandemic: Current Concerns and Future Implications.|pdf=|usr=008}}
| |
| − | {{tp|p=32407464|t=2020. Corona Viruses and the Chemical Senses: Past, Present, and Future.|pdf=|usr=008}}
| |
| − | {{tp|p=32437696|t=2020. Clinical Characteristics and Outcomes of 421 Patients With COVID-19 Treated in a Mobile Cabin Hospital.|pdf=|usr=008}}
| |
| − | {{tp|p=32473172|t=2020. COVID-19 infection among medical staff in Wuhan: A retrospective study from a single-center.|pdf=|usr=008}}
| |
| − | {{tp|p=32533957|t=2020. Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32395696|t=2020. Lung involvement in patients with coronavirus disease-19 (COVID-19): a retrospective study based on quantitative CT findings.|pdf=|usr=008}}
| |
| − | {{tp|p=32435272|t=2020. Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32411496|t=2020. Pulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
| |
| − | {{tp|p=32496917|t=2020. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".|pdf=|usr=008}}
| |
| − | {{tp|p=32496914|t=2020. Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".|pdf=|usr=008}}
| |
| − | {{tp|p=32393409|t=2020. Does intranasal naloxone administration increase the risk of 2019 coronavirus disease transmission?|pdf=|usr=008}}
| |
| − | {{tp|p=32473151|t=2020. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32405079|t=2020. Dynamic changes in routine blood parameters of a severe COVID-19 case.|pdf=|usr=008}}
| |
| − | {{tp|p=32404011|t=2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.|pdf=|usr=008}}
| |
| − | {{tp|p=32462378|t=2020. Clinical features of hemodialysis patients with COVID-19: a single-center retrospective study on 32 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32434304|t=2020. Does the Clinical Spectrum of Coronavirus Disease 2019 (COVID-19) Show Regional Differences?|pdf=|usr=008}}
| |
| − | {{tp|p=32425706|t=2020. We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32407784|t=2020. Cardiac and Muscle Injury Might Partially Contribute to Elevated Aminotransferases in COVID-19 Patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32407783|t=2020. Clinical Characteristics of COVID-19 in Patients With Liver Injury.|pdf=|usr=008}}
| |
| − | {{tp|p=32425338|t=2020. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32535188|t=2020. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.|pdf=|usr=008}}
| |
| − | {{tp|p=32382755|t=2020. Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32382748|t=2020. Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies.|pdf=|usr=008}}
| |
| − | {{tp|p=32409825|t=2020. Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: A cross-sectional study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32407459|t=2020. Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32392337|t=2020. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review.|pdf=|usr=008}}
| |
| − | {{tp|p=32392330|t=2020. The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes.|pdf=|usr=008}}
| |
| − | {{tp|p=32527714|t=2020. Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32526275|t=2020. Risk factors for disease progression in mild to moderate COVID-19 patients- a multi-center observational study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32502644|t=2020. Excretion of SARS-CoV-2 in human breast milk.|pdf=|usr=008}}
| |
| − | {{tp|p=32535147|t=2020. Ibuprofen use and clinical outcomes in COVID-19 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32535148|t=2020. Low risk for SARS-CoV2 symptomatic infection and early complications in pediatric patients during the ongoing CoVID19 epidemics in Lombardy.|pdf=|usr=008}}
| |
| − | {{tp|p=32324898|t=2020. Incidence of Adverse Drug Reactions in COVID-19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32471656|t=2020. Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?|pdf=|usr=008}}
| |
| − | {{tp|p=32418852|t=2020. The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32474884|t=2020. Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32515168|t=2020. Clonal haematopoiesis and COVID-19: A possible deadly liaison.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32516844|t=2020. Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32515500|t=2020. Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.|pdf=|usr=008}}
| |
| − | {{tp|p=32530534|t=2020. Dyspnea: the vanished warning symptom of COVID-19 pneumonia.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32530509|t=2020. Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32530499|t=2020. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.|pdf=|usr=008}}
| |
| − | {{tp|p=32530494|t=2020. Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32525575|t=2020. The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.|pdf=|usr=008}}
| |
| − | {{tp|p=32525558|t=2020. New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32519760|t=2020. Diagnosis of COVID-19 pneumonia despite missing detection of viral nucleic acid and initially inconspicuous radiologic findings.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32310017|t=2020. COVID-19 and stroke-A global World Stroke Organization perspective.|pdf=|usr=008}}
| |
| − | {{tp|p=32522462|t=2020. Association of asthma and its genetic predisposition with the risk of severe COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32535884|t=2020. Nursing home physician with normal chest X-ray and probable COVID-19 based on 18F-FDG PET/CT imaging.|pdf=|usr=008}}
| |
| − | {{tp|p=32519921|t=2020. COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.|pdf=|usr=008}}
| |
| − | {{tp|p=32527675|t=2020. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32434403|t=2020. Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan.|pdf=|usr=008}}
| |
| − | {{tp|p=32429786|t=2020. COVID-19 pneumonia and pregnancy; a systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32419544|t=2020. COVID 19 in neonates.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32533777|t=2020. Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32406001|t=2020. COVID-19 with rheumatic diseases: a report of 5 cases.|pdf=|usr=008}}
| |
| − | {{tp|p=32447647|t=2020. Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers.|pdf=|usr=008}}
| |
| − | {{tp|p=32446267|t=2020. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32520227|t=2020. Neonatal SARS-CoV-2 infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32520225|t=2020. COVID-19 in solid organ transplantation patients: A systematic review.|pdf=|usr=008}}
| |
| − | {{tp|p=32428112|t=2020. Expert recommendations for the care of newborns of mothers with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32428111|t=2020. Why is SARS-CoV-2 infection milder among children?|pdf=|usr=008}}
| |
| − | {{tp|p=32410714|t=2020. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study.|pdf=|usr=008}}
| |
| − | {{tp|p=32513232|t=2020. Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32498689|t=2020. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature.|pdf=|usr=008}}
| |
| − | {{tp|p=32426751|t=2020. The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32452888|t=2020. ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019.|pdf=|usr=008}}
| |
| − | {{tp|p=32371611|t=2020. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019.|pdf=|usr=008}}
| |
| − | {{tp|p=32528774|t=2020. Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient.|pdf=|usr=008}}
| |
| − | {{tp|p=32391234|t=2020. A Hemodialysis Patient with Severe COVID-19 Pneumonia.|pdf=|usr=008}}
| |
| − | {{tp|p=32489751|t=2020. Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32432015|t=2020. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32411566|t=2020. Nifedipine and Amlodipine Are Associated With Improved Mortality and Decreased Risk for Intubation and Mechanical Ventilation in Elderly Patients Hospitalized for COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32528785|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mimicking as Pulmonary Tuberculosis in an Inmate.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32399342|t=2020. A Case of a COVID-19-positive Patient.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32483507|t=2020. Coronavirus Disease 2019 (COVID-19) Can Masquerade as Acute Postoperative Periprosthetic Joint Infection.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32467810|t=2020. Coronavirus Disease 2019 (COVID-19) in Cancer Patients.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32382587|t=2020. Cardiac Troponin-I may be a predictor of complications and mortality in COVID-19 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32385891|t=2020. Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS-CoV-2 (COVID-19) pandemic emergency: A quick review for a quick consultation.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32378293|t=2020. Update on COVID-19 Effects in Dermatology Specialty.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32406114|t=2020. Psychological effects of COVID-19 on parenting and maternal-fetal mental health.|pdf=|usr=008}}
| |
| − | {{tp|p=32468230|t=2020. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).|pdf=|usr=008}}
| |
| − | {{tp|p=32425701|t=2020. Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract.|pdf=|usr=008}}
| |
| − | {{tp|p=32447101|t=2020. Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.|pdf=|usr=008}}
| |
| − | {{tp|p=32447100|t=2020. COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes.|pdf=|usr=008}}
| |
| − | {{tp|p=32416321|t=2020. Patients with diabetes are at higher risk for severe illness from COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32452598|t=2020. In response: Diabetes is a risk factor for the progression and prognosis of COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32426928|t=2020. The diabetic lung: An easy target for SARS-CoV-2?|pdf=|usr=008}}
| |
| − | {{tp|p=32438331|t=2020. Diabetes and metabolic syndrome as risk factors for COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32388332|t=2020. SARS-CoV-2 infection and glucose homeostasis in pregnancy. What about antenatal corticosteroids?|pdf=|usr=008}}
| |
| − | {{tp|p=32402930|t=2020. Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.).|pdf=|usr=008}}
| |
| − | {{tp|p=32388330|t=2020. Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review.|pdf=|usr=008}}
| |
| − | {{tp|p=32502958|t=2020. Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings.|pdf=|usr=008}}
| |
| − | {{tp|p=32473903|t=2020. Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32473904|t=2020. Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).|pdf=|usr=008}}
| |
| − | {{tp|p=32473902|t=2020. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).|pdf=|usr=008}}
| |
| − | {{tp|p=32438328|t=2020. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review.|pdf=|usr=008}}
| |
| − | {{tp|p=32526625|t=2020. Multimorbidity and SARS-CoV-2 infection in UK Biobank.|pdf=|usr=008}}
| |
| − | {{tp|p=32311651|t=2020. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32315948|t=2020. Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?|pdf=|usr=008}}
| |
| − | {{tp|p=32406594|t=2020. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.|pdf=|usr=008}}
| |
| − | {{tp|p=32319200|t=2020. Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19).|pdf=|usr=008}}
| |
| − | {{tp|p=32446795|t=2020. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32446801|t=2020. SARS-CoV-2 and diabetes: New challenges for the disease.|pdf=|usr=008}}
| |
| − | {{tp|p=32446798|t=2020. Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32524609|t=2020. COVID-19 in Australian health care workers: early experience of the Royal Melbourne Hospital emphasises the importance of community acquisition.|pdf=|usr=008}}
| |
| − | {{tp|p=32519352|t=2020. The possible protective role of alpha-synuclein against the SARS-CoV-2 infections in patients with Parkinson's disease.|pdf=|usr=008}}
| |
| − | {{tp|p=32515393|t=2020. Long term complications and rehabilitation of COVID-19 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32515389|t=2020. COVID-19 in children: Epidemiology, presentation, diagnosis and management.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32515378|t=2020. Clinical features, diagnosis and management of COVID-19 patients in the outdoor setting.|pdf=|usr=008}}
| |
| − | {{tp|p=32329797|t=2020. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.|pdf=|usr=008}}
| |
| − | {{tp|p=32530453|t=2020. Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy.|pdf=|usr=008}}
| |
| − | {{tp|p=32302270|t=2020. Managing COVID-19 in Patients With Cancer: A Double Blow for Oncologists.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32531754|t=2020. Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32360400|t=2020. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory.|pdf=|usr=008}}
| |
| − | {{tp|p=32533989|t=2020. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.|pdf=|usr=008}}
| |
| − | {{tp|p=32531325|t=2020. Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study.|pdf=|usr=008}}
| |
| − | {{tp|p=32442557|t=2020. Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?|pdf=|usr=008}}
| |
| − | {{tp|p=32416121|t=2020. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32407746|t=2020. Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32278764|t=2020. COVID-19 and diabetes: Knowledge in progress.|pdf=|usr=008}}
| |
| − | {{tp|p=32179126|t=2020. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.|pdf=|usr=008}}
| |
| − | {{tp|p=32472191|t=2020. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.|pdf=|usr=008}}
| |
| − | {{tp|p=32405783|t=2020. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.|pdf=|usr=008}}
| |
| − | {{tp|p=32473875|t=2020. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32529474|t=2020. Does Ibuprofen Worsen COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32527380|t=2020. SARS-CoV-2 in the Employees of a Large University Hospital.|pdf=|usr=008}}
| |
| − | {{tp|p=32519943|t=2020. Hospital Admission in Children and Adolescents With COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32499091|t=2020. (Mis-)understanding COVID-19 and digit ratio: Methodological and statistical issues in Manning and Fink (2020).|pdf=|usr=008}}
| |
| − | {{tp|p=32419720|t=2020. Understanding COVID-19: Digit ratio (2D:4D) and sex differences in national case fatality rates.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32535547|t=2020. Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32407284|t=2020. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32497001|t=2020. Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32521222|t=2020. Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.|pdf=|usr=008}}
| |
| − | {{tp|p=32390285|t=2020. SARS-CoV-2 testing and outcomes in the first 30 days after the first case of COVID-19 at an Australian children's hospital.|pdf=|usr=008}}
| |
| − | {{tp|p=32515651|t=2020. Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32449100|t=2020. Incidentally discovered COVID-19 in low-suspicion patients-a threat to front line health care workers.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32475769|t=2020. Consecuencias de la COVID-19 sobre las personas con diabetes.|pdf=|usr=008}}
| |
| − | {{tp|p=32425489|t=2020. RECOMENDACIONES Y MANEJO PRACTICO DE LA GESTANTE CON COVID-19: SCOPING REVIEW.|pdf=|usr=008}}
| |
| − | {{tp|p=32425488|t=2020. Prevencion y tratamiento del Covid-19 en la poblacion pediatrica desde una perspectiva familiar y comunitaria.|pdf=|usr=008}}
| |
| − | {{tp|p=32422280|t=2020. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking.|pdf=|usr=008}}
| |
| − | {{tp|p=32374248|t=2020. Characteristics of disease progress in patients with coronavirus disease 2019 in Wuhan, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32460927|t=2020. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32430084|t=2020. Outbreak of COVID-19 in a family, Wenzhou, China.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32488522|t=2020. Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32388565|t=2020. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.|pdf=|usr=008}}
| |
| − | {{tp|p=32388547|t=2020. Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32383763|t=2020. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.|pdf=|usr=008}}
| |
| − | {{tp|p=32383758|t=2020. SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32523932|t=2020. Should the Management of Embolic Stroke in the Elderly Be Changed if They Also Have COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32523931|t=2020. Fatal Ischaemic Stroke During COVID-19 and Acute Lung Injury.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32523924|t=2020. Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32383239|t=2020. Diabetes or endocrinopathy admitted in the COVID-19 ward.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32307717|t=2020. COVID-19 diagnosis does not rule out other concomitant diseases.|pdf=|usr=008}}
| |
| − | {{tp|p=32404898|t=2020. Diabetes and COVID-19: evidence, current status and unanswered research questions.|pdf=|usr=008}}
| |
| − | {{tp|p=32379084|t=2020. Daily pool testing of nasopharyngeal self-obtained swaps of healthcare professionals with definite COVID-19 exposition.|pdf=|usr=008}}
| |
| − | {{tp|p=32424571|t=2020. Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32530584|t=2020. Natural History of Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32516853|t=2020. Publication of COVID-19 case reports: are we hurrying?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32521564|t=2020. Viral enanthema in oral mucosa: a possible diagnostic challenge in the COVID-19 pandemic.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32515518|t=2020. Postnatal SARS-CoV-2 Infection and Immunological Reaction: A Prospective Family Cohort Study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32519809|t=2020. What we know so far about Coronavirus Disease 2019 in children: A meta-analysis of 551 laboratory-confirmed cases.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32529643|t=2020. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2.|pdf=|usr=008}}
| |
| − | {{tp|p=32434211|t=2020. Viral and host factors related to the clinical outcome of COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32516274|t=2020. Prone Positioning for Pregnant Women With Hypoxemia Due to Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}}
| |
| − | {{tp|p=32516273|t=2020. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review.|pdf=|usr=008}}
| |
| − | {{tp|p=32428215|t=2020. SARS-COV-2 pandemic: the significance of underlying conditions.|pdf=|usr=008}}
| |
| − | {{tp|p=32513036|t=2020. Disparate Nasopharyngeal and Tracheal COVID-19 Diagnostic Test Results in a Patient With a Total Laryngectomy.|pdf=|usr=008}}
| |
| − | {{tp|p=32520362|t=2020. What Are the Newest Effects of COVID-19 in Children?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32525645|t=2020. Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old.|pdf=|usr=008}}
| |
| − | {{tp|p=32525644|t=2020. Three Hypotheses About Children COVID19.|pdf=|usr=008}}
| |
| − | {{tp|p=32520888|t=2020. Clinical Analysis of 25 COVID-19 Infections in Children.|pdf=|usr=008}}
| |
| − | {{tp|p=32522783|t=2020. Severe Coronavirus Bronchiolitis in the Pre-COVID-19 Era.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32417144|t=2020. Active smoking and severity of coronavirus disease 2019 (COVID-19): The use of significance testing leads to an erroneous conclusion.|pdf=|usr=008}}
| |
| − | {{tp|p=32499172|t=2020. Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results.|pdf=|usr=008}}
| |
| − | {{tp|p=32439289|t=2020. Active smoking and COVID-19: a double-edged sword.|pdf=|usr=008}}
| |
| − | {{tp|p=32192856|t=2020. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}}
| |
| − | {{tp|p=32532661|t=2020. Management and outcomes of post-acute COVID-19 patients in Northern Italy.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32493595|t=2020. Delayed umbilical cord clamping and breastfeeding after childbirth in mothers affected by COVID 19: Recommended or not?|pdf=|usr=008}}
| |
| − | {{tp|p=32456886|t=2020. Is termination of early pregnancy indicated in women with COVID-19?|pdf=|usr=008}}
| |
| − | {{tp|p=32425299|t=2020. Prolonged viral persistence in COVID-19 second trimester pregnant patient.|pdf=|usr=008}}
| |
| − | {{tp|p=32425298|t=2020. Covid-19 during pregnancy: a case series from an universally tested population from the north of Portugal.|pdf=|usr=008}}
| |
| − | {{tp|p=32425297|t=2020. SARS-CoV-2 infection in very preterm pregnancy: experiences from two cases.|pdf=|usr=008}}
| |
| − | {{tp|p=32405137|t=2020. Prone positioning and high-flow oxygen improved respiratory function in a 25-week pregnant woman with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32439245|t=2020. Vaginal delivery in a woman infected with SARS-CoV-2 - The first case reported in Portugal.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32424745|t=2020. SARS-COV-2 infection in children and newborns: a systematic review.|pdf=|usr=008}}
| |
| − | {{tp|p=32495147|t=2020. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks.|pdf=|usr=008}}
| |
| − | {{tp|p=32495145|t=2020. COVID-19 in children: patiently and critically evaluate the scientific evidence.|pdf=|usr=008}}
| |
| − | {{tp|p=32391719|t=2020. Cardiovascular disease and COVID-19: les liaisons dangereuses.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32385648|t=2020. Clinical and radiological changes of hospitalised patients with COVID-19 pneumonia from disease onset to acute exacerbation: a multicentre paired cohort study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32430431|t=2020. Smoking, ACE-2, and COVID-19: Ongoing Controversies.|pdf=|usr=008}}
| |
| − | {{tp|p=32430427|t=2020. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32398296|t=2020. Arterial hypertension and the risk of severity and mortality of COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32381497|t=2020. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.|pdf=|usr=008}}
| |
| − | {{tp|p=32366490|t=2020. Reply to: "Current smoking is not associated with COVID-19".|pdf=|usr=008}}
| |
| − | {{tp|p=32350106|t=2020. Current smoking is not associated with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32373997|t=2020. Outbreak of COVID-19 infection in children: fear and serenity.|pdf=|usr=008}}
| |
| − | {{tp|p=32534910|t=2020. Clinical Characteristics and Outcome for Four SARS-CoV-2-infected Cancer Patients Treated with Immune Checkpoint Inhibitors.|pdf=|usr=008}}
| |
| − | {{tp|p=32475747|t=2020. Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?|pdf=|usr=008}}
| |
| − | {{tp|p=32405138|t=2020. Reply to Peng He, Xiaohui Wang, and Hao Li's Letter to the Editor re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.|pdf=|usr=008}}
| |
| − | {{tp|p=32345521|t=2020. Re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025.|pdf=|usr=008}}
| |
| − | {{tp|p=32431289|t=2020. Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.|pdf=|usr=008}}
| |
| − | {{tp|p=32400362|t=2020. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.|pdf=|usr=008}}
| |
| − | {{tp|p=32519618|t=2020. Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience.|pdf=|usr=008}}
| |
| − | {{tp|p=32519617|t=2020. Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32482250|t=2020. Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?|pdf=|usr=008}}
| |
| − | {{tp|p=32535599|t=2020. Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32391384|t=2020. COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?|pdf=|usr=008}}
| |
| − | {{tp|p=32405974|t=2020. Organ function support in patients with coronavirus disease 2019: Tongji experience.|pdf=|usr=008}}
| |
| − | {{tp|p=32435649|t=2020. Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics.|pdf=|usr=008}}
| |
| − | {{tp|p=32426363|t=2020. Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China.|pdf=|usr=008}}
| |
| − | {{tp|p=32426362|t=2020. Covid-19: A Dynamic Analysis of Fatality Risk in Italy.|pdf=|usr=008}}
| |
| − | {{tp|p=32391367|t=2020. The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32426311|t=2020. Novel Coronavirus Disease 2019 Infection in Children: The Dark Side of a Worldwide Outbreak.|pdf=|usr=008}}
| |
| − | {{tp|p=32411652|t=2020. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.|pdf=|usr=008}}
| |
| − | {{tp|p=32456461|t=2020. Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?|pdf=|usr=008}}
| |
| − | {{tp|p=32437750|t=2020. Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: A Large Cohort from South America.|pdf=|usr=008}}
| |
| − | {{tp|p=32479824|t=2020. Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.|pdf=|usr=008}}
| |
| − | {{tp|p=32479823|t=2020. Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study.|pdf=|usr=008}}
| |
| − | {{tp|p=32446696|t=2020. Initial Gastrointestinal Manifestations in Patients with SARS-CoV-2 in 112 patients from Veracruz (Southeastern Mexico).|pdf=|usr=008}}
| |
| − | {{tp|p=32442561|t=2020. COVID-19 in Liver Transplant Recipients: An Initial Experience from the U.S. Epicenter.|pdf=|usr=008}}
| |
| − | {{tp|p=32425229|t=2020. Focusing on gastrointestinal symptoms in COVID-19 is far from enough.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32422208|t=2020. Associations between Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality among Patients with COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32407807|t=2020. Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32534808|t=2020. Cancer patients affected by COVID-19: Experience from Milan, Lombardy.|pdf=|usr=008}}
| |
| − | {{tp|p=32527955|t=2020. COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32338805|t=2020. Tobacco use and vaping in the COVID-19 era.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32531138|t=2020. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study.|pdf=|usr=008}}
| |
| − | {{tp|p=32515076|t=2020. COVID-19 in pancreas transplant recipients.|pdf=|usr=008}}
| |
| − | {{tp|p=32521074|t=2020. COVID-19 in Lung Transplant Recipients.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32533615|t=2020. Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32530409|t=2020. Rethinking the First COVID-19 Death in Turkey.|pdf=|usr=008}}
| |
| − | {{tp|p=32530408|t=2020. Acute Respiratory Failure in COVID-19 Pneumoniae: The Best Interface for an Optimal Management. A South Italian Experience.|pdf=|usr=008}}
| |
| − | {{tp|p=32522535|t=2020. Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.|pdf=|usr=008}}
| |
| − | {{tp|p=32391676|t=2020. [Follow-up testing of viral nucleic acid in discharged patients with moderate type of COVID-19].|pdf=|usr=008}}
| |
| − | {{tp|p=32391658|t=2020. [Management of COVID-19: the Zhejiang experience].|pdf=|usr=008}}
| |
| − | {{tp|p=32434635|t=2020. [Coronavirus disease 2019 and hypertension in 2 children].|pdf=|usr=008}}
| |
| − | {{tp|p=32186171|t=2020. [Using the big data ofinternet to understand coronavirus disease 2019's symptom characteristics: a big data study].|pdf=|usr=008}}
| |
| − | {{tp|p=32102140|t=2020. [Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives].|pdf=|usr=008}}
| |
| − | {{tp|p=32023678|t=2020. [Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives].|pdf=|usr=008}}
| |
| − | {{tp|p=32450631|t=2020. [The analysis of clinical characteristics of 34 novel coronavirus pneumonia cases in Ningxia Hui autonomous region].|pdf=|usr=008}}
| |
| − | {{tp|p=32087623|t=2020. [Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with coronavirus disease 2019].|pdf=|usr=008}}
| |
| − | {{tp|p=32026671|t=2020. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].|pdf=|usr=008}}
| |
| − | {{tp|p=32061198|t=2020. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].|pdf=|usr=008}}
| |
| − | {{tp|p=32061066|t=2020. [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing].|pdf=|usr=008}}
| |
| − | {{tp|p=32294816|t=2020. [Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].|pdf=|usr=008}}
| |
| − | {{tp|p=32294812|t=2020. [Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].|pdf=|usr=008}}
| |
| − | {{tp|p=32527345|t=2020. [Clinical analysis of 23 patients with coronavirus disease 2019 in Xinyang City of Henan Province].|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32527341|t=2020. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].|pdf=|usr=008}}
| |
| − | {{tp|p=32527340|t=2020. [Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].|pdf=|usr=008}}
| |
| − | {{tp|p=32394688|t=2020. [Chronic granulocytic leukemia with COVID-19 pneumonia: a case report].|pdf=|usr=008}}
| |
| − | {{tp|p=32149486|t=2020. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report].|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32157848|t=2020. [Practice and Reflection on the Battle against COVID-19 by Guangdong Medical Aid Team in the city of Honghu].|pdf=|usr=008}}
| |
| − | {{tp|p=32388946|t=2020. [Screening and management of asymptomatic infection of 2019-novel coronavirus].|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32064855|t=2020. [Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province].|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32474034|t=2020. Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.|pdf=|usr=008}}
| |
| − | {{tp|p=32474047|t=2020. Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32474043|t=2020. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32474042|t=2020. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32474041|t=2020. Cancer in intensive care unit patients with COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32474033|t=2020. Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32474032|t=2020. COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.|pdf=|usr=008}}
| |
| − | {{tp|p=32473236|t=2020. Ethnicity profiles of COVID-19 admissions and outcomes.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32473231|t=2020. Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.|pdf=|usr=008}}
| |
| − | {{tp|p=32445728|t=2020. Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32416124|t=2020. Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates.|pdf=|usr=008}}
| |
| − | {{tp|p=32425274|t=2020. Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients.|pdf=|usr=008}}
| |
| − | {{tp|p=32417313|t=2020. Unfavorable outcomes in pregnant patients with COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32417309|t=2020. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32405109|t=2020. Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.|pdf=|usr=008}}
| |
| − | {{tp|p=32407757|t=2020. Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.|pdf=|usr=008}}
| |
| − | {{tp|p=32502509|t=2020. The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32283155|t=2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32142929|t=2020. Corona Virus Disease 2019, a growing threat to children?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32112886|t=2020. Characteristics of COVID-19 infection in Beijing.|pdf=|usr=008}}
| |
| − | {{tp|p=32525829|t=2020. Different outcome of COVID-19 in members of a family.|pdf=|usr=008}}
| |
| − | {{tp|p=32525828|t=2020. Epidemiological and clinical characteristics of COVID-19 patients in Nantong, China.|pdf=|usr=008}}
| |
| − | {{tp|p=32382746|t=2020. Clinical characteristics of patients with COVID-19 in Japan: a single-center case series.|pdf=|usr=008}}
| |
| − | {{tp|p=32405329|t=2020. COVID-19 transmission and blood transfusion: A case report.|pdf=|usr=008}}
| |
| − | {{tp|p=32534945|t=2020. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32528233|t=2020. SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.|pdf=|usr=008}}
| |
| − | {{tp|p=32489403|t=2020. COVID-19: An update from England's high consequence infectious diseases intensive care unit leads.|pdf=|usr=008}}
| |
| − | {{tp|p=32494896|t=2020. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.|pdf=|usr=008}}
| |
| − | {{tp|p=32525402|t=2020. Atypical Presentation of Novel Coronavirus Disease 2019 in a Peritoneal Dialysis Patient.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32449328|t=2020. Seventy-two Hours, Targeting Time from First COVID-19 Symptom Onset to Hospitalization.|pdf=|usr=008}}
| |
| − | {{tp|p=32383171|t=2020. Asymptomatic cases with SARS-CoV-2 infection.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32410245|t=2020. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32401361|t=2020. Clinical characteristics of rehospitalized patients with COVID-19 in China.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32293710|t=2020. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32343428|t=2020. Three Taiwan's domestic family cluster infections of coronavirus disease 2019.|pdf=|usr=008}}
| |
| − | {{tp|p=32330313|t=2020. Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.|pdf=|usr=008}}
| |
| − | {{tp|p=32320084|t=2020. Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=008}}
| |
| − | {{tp|p=32281653|t=2020. Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32275072|t=2020. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19.|pdf=|usr=008}}
| |
| − | {{tp|p=32475799|t=2020. A case of COVID-19 with long duration of viral shedding.|pdf=|usr=008}}
| |
| − | {{tp|p=32527700|t=2020. First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32494855|t=2020. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.|pdf=|usr=008}}
| |
| − | {{tp|p=32494856|t=2020. COVID-19 in teriflunomide-treated patients with multiple sclerosis.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32405091|t=2020. Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region.|pdf=|usr=008}}
| |
| − | {{tp|p=32407719|t=2020. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 (COVID-19) at a Tertiary Care Medical Center in New York City.|pdf=|usr=008}}
| |
| − | {{tp|p=32452978|t=2020. Prolonged fecal shedding of SARS-CoV-2 in pediatric patients. A quantitative evidence synthesis.|pdf=|usr=008}}
| |
| − | '''others'''
| |
| − | {{tp|p=32276139|t=2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster |pdf=|usr=}}
| |
| − | {{tp|p=32276140|t=2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |pdf=|usr=}}
| |
| − | {{tp|p=32283499|t=2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers |pdf=|usr=}}
| |
| − | {{tp|p=32228738|t=ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease |pdf=|usr=}}
| |
| − | {{tp|p=32256706|t=2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?|pdf=|usr=}}
| |
| − | {{tp|p=32134381|t=2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China |pdf=|usr=}}
| |
| − | {{tp|p=C7141546|t=ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
| |
| − | {{tp|p=32269089|t=2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32307025|t=ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?|pdf=|usr=}}
| |
| − | {{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?|pdf=|usr=}}
| |
| − | {{tp|p=32253068|t=2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |pdf=|usr=}}
| |
| − | {{tp|p=32335513|t=2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis |pdf=|usr=}}
| |
| − | {{tp|p=32334645|t=2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32332856|t=ä. COVID-19 in persons with haematological cancers |pdf=|usr=}}
| |
| − | {{tp|p=32303807|t=ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32339776|t=2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease |pdf=|usr=}}
| |
| − | {{tp|p=32320740|t=ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32302077|t=ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32289171|t=ä. Cardiac drugs and outcome in COVID-19: Reply |pdf=|usr=}}
| |
| − | {{tp|p=32289168|t=ä. Cardiac drugs and outcome in COVID - 19 |pdf=|usr=}}
| |
| − | {{tp|p=32379903|t=2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32369615|t=2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression |pdf=|usr=}}
| |
| − | {{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | *[https://www.boston25news.com/news/health/high-blood-pressure-drugs-cleared-covid/UC5LTCKKKVDETBWKJDZ2P776XY/ ACEI/AT1RA not risky ?]
| |
| − |
| |
| − | {{tp|p=32320270|t=2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms |pdf=|usr=}}
| |
| − | {{tp|p=32259878|t=ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32310015|t=2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32347572|t=2020. Outcome of Parkinson s Disease Patients Affected by COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32360210|t=2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32386796|t=ä. Children are at risk from COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32324968|t=2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?|pdf=|usr=}}
| |
| − | {{tp|p=32413819|t=2020. Vitamin D concentrations and COVID-19 infection in UK Biobank |pdf=|usr=}}
| |
| − | {{tp|p=32291196|t=2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
| |
